State Street
CLPT icon

State Street’s ClearPoint Neuro CLPT Stock Holding History

State Street’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
816,547
+136,728
+20% +$1.71M ﹤0.01% 2526
2026
Q1 		$6.19M Buy
679,819
+51,758
+8% +$654K ﹤0.01% 2852
2025
Q4 		$8.59M Buy
628,061
+145,411
+30% +$2.7M ﹤0.01% 2720
2025
Q3 		$10.5M Buy
482,650
+149,269
+45% +$1.76M ﹤0.01% 2610
2025
Q2 		$3.98M Buy
333,381
+207,533
+165% +$2.61M ﹤0.01% 3039
2025
Q1 		$1.5M Buy
125,848
+9,600
+8% +$149K ﹤0.01% 3339
2024
Q4 		$1.79M Buy
116,248
+11,046
+10% +$143K ﹤0.01% 3352
2024
Q3 		$1.18M Sell
105,202
-24,300
-19% -$233K ﹤0.01% 3459
2024
Q2 		$698K Sell
129,502
-286,774
-69% -$1.66M ﹤0.01% 3526
2024
Q1 		$2.83M Buy
416,276
+67,378
+19% +$471K ﹤0.01% 3163
2023
Q4 		$2.37M Buy
348,898
+21,684
+7% +$123K ﹤0.01% 3257
2023
Q3 		$1.64M Buy
327,214
+19,900
+6% +$118K ﹤0.01% 3404
2023
Q2 		$2.22M Buy
307,314
+238,412
+346% +$2.03M ﹤0.01% 3356
2023
Q1 		$582K Buy
68,902
+2,700
+4% +$23.7K ﹤0.01% 3692
2022
Q4 		$561K Buy
66,202
+10,100
+18% +$95.7K ﹤0.01% 3729
2022
Q3 		$581K Buy
56,102
+300
+0.5% +$3.95K ﹤0.01% 3723
2022
Q2 		$728K Sell
55,802
-247,533
-82% -$2.53M ﹤0.01% 3703
2022
Q1 		$3.16M Buy
303,335
+2,125
+0.7% +$19.3K ﹤0.01% 3392
2021
Q4 		$3.38M Sell
301,210
-9,661
-3% -$145K ﹤0.01% 3434
2021
Q3 		$5.52M Buy
310,871
+36,822
+13% +$691K ﹤0.01% 3186
2021
Q2 		$5.23M Buy
+274,049
New +$5.3M ﹤0.01% 3226

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street's CLPT Position: Q2 2026 in Review

State Street increased its ClearPoint Neuro (CLPT) stake by 20% in Q2 2026, buying an estimated $1.71M and bringing the position to 816,547 shares worth $14.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2526.

State Street first reported a position in CLPT in Q2 2021 and has held it in 21 quarters since. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • State Street held 816,547 shares of ClearPoint Neuro worth $14.6M as of Q2 2026.
  • State Street bought 136,728 ClearPoint Neuro shares in Q2 2026, an estimated $1.71M.
  • ClearPoint Neuro made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2526 holding.
  • State Street first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 21 quarters since.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.